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Introduction
Antimicrobial resistance is a serious global threat that
needs urgent attention. Antimicrobial stewardship (AS)
programs were proven to be effective in reducing anti-
biotic days in adults. Pediatric-specific data about the
effectiveness of implementation of such programs are
limited especially in the Middle East.
Objectives
Our primary objective was to identify the top three anti-
biotics and measure their specific days of therapy (DOT)
per 1000 pediatric intensive care unit (PICU) days per
quarter before and after the AS intervention.
Methods
We conducted a pilot prospective quality-improvement
interventional study in a 20-bed PICU in a specialized ter-
tiary care children’s hospital in Riyadh, Saudi Arabia from
April to December 2014. Data about antimicrobial indica-
tion and utilization were gathered from study-designed
forms. An AS member from pediatric infectious disease
team rounded three times per week on all patients in
PICU and provided antibiotic-related recommendations
based on available bedside information and ensured adher-
ence to antimicrobial restriction policy. Intervention also
included educational sessions to physicians and nurses
about proper use of antibiotics.
Results
During the study period, 648 children out of 898
PICU admissions (72.2%) were utilizing antimicrobials.
Vancomycin, Pipracillin/Tazobactam and Meropenum
represented approximately 60% of the 36 antimicrobials
used. Per quarter, antibiotic-specific DOT dropped from
348.5 to 320.5 (8.0%, p-value <0.001) for Vancomycin,
356.2 to 294.7 (17.3%, p-value <0.001) for Pipracillin/
Tazobactam, 162.0 to 111.1 (31.4%, p-value <0.001) for
Meropenum.
Conclusion
Education and bedside real-time AS recommendations sig-
nificantly dropped the use of Meropenum, Pipracillin/
Tazobactam and Vancomycin. Moreover, AS program
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